Grantham, Mayo, Van Otterloo & Co (GMO)’s Akamai AKAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-14,433
Closed -$1.66M 664
2026
Q1
$1.66M Sell
14,433
-131,790
-90% -$13.2M ﹤0.01% 452
2025
Q4
$12.8M Sell
146,223
-105,099
-42% -$8.65M 0.03% 220
2025
Q3
$19M Buy
251,322
+74,791
+42% +$5.76M 0.05% 175
2025
Q2
$14.1M Buy
176,531
+58,181
+49% +$4.52M 0.04% 205
2025
Q1
$9.53M Sell
118,350
-2,600
-2% -$233K 0.03% 247
2024
Q4
$11.6M Sell
120,950
-164,760
-58% -$16.2M 0.04% 242
2024
Q3
$28.8M Sell
285,710
-30,722
-10% -$2.99M 0.09% 149
2024
Q2
$28.5M Buy
316,432
+203,764
+181% +$19.7M 0.1% 138
2024
Q1
$12.3M Buy
112,668
+80,939
+255% +$9.33M 0.04% 239
2023
Q4
$3.76M Sell
31,729
-5,472
-15% -$609K 0.02% 304
2023
Q3
$3.96M Buy
+37,201
New +$3.7M 0.02% 336
2022
Q4
Sell
-88,600
Closed -$7.12M 713
2022
Q3
$7.12M Buy
88,600
+9,000
+11% +$819K 0.04% 283
2022
Q2
$7.27M Buy
+79,600
New +$8.29M 0.04% 300
2022
Q1
Sell
-100,500
Closed -$11.8M 689
2021
Q4
$11.8M Buy
100,500
+74,400
+285% +$8.18M 0.06% 226
2021
Q3
$2.73M Sell
26,100
-45,300
-63% -$5.18M 0.01% 417
2021
Q2
$8.32M Buy
71,400
+21,365
+43% +$2.38M 0.04% 270
2021
Q1
$5.1M Buy
50,035
+44,175
+754% +$4.56M 0.03% 313
2020
Q4
$615K Hold
5,860
﹤0.01% 650
2020
Q3
$648K Buy
5,860
+3,700
+171% +$411K ﹤0.01% 591
2020
Q2
$231K Sell
2,160
-300
-12% -$30.2K ﹤0.01% 696
2020
Q1
$225K Buy
+2,460
New +$228K ﹤0.01% 691
2015
Q4
Sell
-4,515
Closed -$312K 547
2015
Q3
$312K Sell
4,515
-179,967
-98% -$13M ﹤0.01% 516
2015
Q2
$12.9M Sell
184,482
-3,200
-2% -$237K 0.04% 173
2015
Q1
$13.3M Sell
187,682
-5,300
-3% -$350K 0.04% 164
2014
Q4
$12.2M Sell
192,982
-4,610
-2% -$278K 0.03% 175
2014
Q3
$11.8M Buy
197,592
+45,192
+30% +$2.72M 0.03% 194
2014
Q2
$9.31M Buy
+152,400
New +$8.48M 0.03% 207

Other funds holding AKAM

Grantham, Mayo, Van Otterloo & Co (GMO)'s AKAM Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Akamai (AKAM) in Q2 2026, closing a stake of 14,433 shares — an estimated $1.66M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in AKAM in Q2 2014 and held it in 27 quarters. The position peaked at $28.8M in Q3 2024. 801 funds tracked by Wall St. Rank hold AKAM as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Akamai position as of Q2 2026 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 14,433 Akamai shares in Q2 2026, an estimated $1.66M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Akamai in Q2 2014 and held it in 27 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Akamai position peaked at $28.8M in Q3 2024.
  • 801 funds tracked by Wall St. Rank held Akamai as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.